BackCalliditas Therapeutics AB Overview

Calliditas Therapeutics AB Profit Margin

Calliditas Therapeutics AB (CALT) has a profit margin of -821598.82%, below the Healthcare sector average of 17.63%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-288936.04%
↓ 5.68% YoY

As of Aug 2026

Annual Profit Margin (TTM)

-821598.82%
↓ 19084.37% YoY

Trailing 12 months ending Aug 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Calliditas Therapeutics AB (CALT) FAQ

The latest profit margin for CALT is -821598.82% as of August 2026. That compares with -4282.65% in the prior-year period — down 19084.4% year over year. That is below the Healthcare sector average of 17.63%. Investors often review this figure alongside Calliditas Therapeutics AB's historical trend and sector peers before judging valuation or financial health.

Over the past year, CALT's profit margin moved from -4282.65% to -821598.82% — a 19084.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Calliditas Therapeutics AB's valuation or profitability profile.

Against Healthcare companies, CALT currently prints -821598.82% for profit margin, while the sector average sits near 17.63%. That is roughly 4660727.9% below the sector mean. Large gaps often invite a closer look at Calliditas Therapeutics AB's growth, margins, and balance sheet.

Profit Margin shows how effectively Calliditas Therapeutics AB converts resources into returns. At -821598.82%, CALT may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -4282.65% in the prior-year period — down 19084.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CALT's profit margin (-821598.82%), review year-over-year change from -4282.65%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.